101 related articles for article (PubMed ID: 19716840)
21. Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.
Deng WG; Nishizaki M; Fang B; Roth JA; Ji L
Biochem Biophys Res Commun; 2007 Apr; 355(4):993-9. PubMed ID: 17328863
[TBL] [Abstract][Full Text] [Related]
22. Fragile histidine triad protein: structure, function, and its association with tumorogenesis.
Hassan MI; Naiyer A; Ahmad F
J Cancer Res Clin Oncol; 2010 Mar; 136(3):333-50. PubMed ID: 20033706
[TBL] [Abstract][Full Text] [Related]
23. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.
Golebiowski F; Szulc A; Szutowicz A; Pawelczyk T
Arch Biochem Biophys; 2004 Aug; 428(2):160-4. PubMed ID: 15246872
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.
Andriani F; Roz E; Caserini R; Conte D; Pastorino U; Sozzi G; Roz L
J Thorac Oncol; 2012 Apr; 7(4):631-42. PubMed ID: 22425911
[TBL] [Abstract][Full Text] [Related]
25. Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line.
Cavazzoni A; Galetti M; Fumarola C; Alfieri RR; Roz L; Andriani F; Carbognani P; Rusca M; Sozzi G; Petronini PG
Cancer Lett; 2007 Feb; 246(1-2):69-81. PubMed ID: 16616810
[TBL] [Abstract][Full Text] [Related]
26. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
[TBL] [Abstract][Full Text] [Related]
27. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant.
Ottey M; Han SY; Druck T; Barnoski BL; McCorkell KA; Croce CM; Raventos-Suarez C; Fairchild CR; Wang Y; Huebner K
Br J Cancer; 2004 Nov; 91(9):1669-77. PubMed ID: 15494723
[TBL] [Abstract][Full Text] [Related]
28. Fragile gene product, Fhit, in oxidative and replicative stress responses.
Okumura H; Ishii H; Pichiorri F; Croce CM; Mori M; Huebner K
Cancer Sci; 2009 Jul; 100(7):1145-50. PubMed ID: 19486340
[TBL] [Abstract][Full Text] [Related]
29. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
[TBL] [Abstract][Full Text] [Related]
30. Study of the efficacy and mechanism of ALA-mediated photodynamic therapy on human hepatocellular carcinoma cell.
Yow CM; Wong CK; Huang Z; Ho RJ
Liver Int; 2007 Mar; 27(2):201-8. PubMed ID: 17311614
[TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
32. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
Jayachandran G; Sazaki J; Nishizaki M; Xu K; Girard L; Minna JD; Roth JA; Ji L
Cancer Res; 2007 Nov; 67(21):10379-88. PubMed ID: 17974981
[TBL] [Abstract][Full Text] [Related]
33. Fluorimetric detection of enzymatic activity associated with the human tumor suppressor Fhit protein.
Asensio AC; Oaknin S; Rotllán P
Biochim Biophys Acta; 1999 Jul; 1432(2):396-400. PubMed ID: 10407161
[TBL] [Abstract][Full Text] [Related]
34. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
Zanesi N; Pekarsky Y; Croce CM
Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
[TBL] [Abstract][Full Text] [Related]
35. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression.
Semba S; Huebner K
Mol Cancer Res; 2006 Aug; 4(8):529-38. PubMed ID: 16885564
[TBL] [Abstract][Full Text] [Related]
36. Fhit tumor suppressor: guardian of the preneoplastic genome.
Pichiorri F; Palumbo T; Suh SS; Okamura H; Trapasso F; Ishii H; Huebner K; Croce CM
Future Oncol; 2008 Dec; 4(6):815-24. PubMed ID: 19086848
[TBL] [Abstract][Full Text] [Related]
37. Fhit modulates the DNA damage checkpoint response.
Ishii H; Mimori K; Inoue H; Inageta T; Ishikawa K; Semba S; Druck T; Trapasso F; Tani K; Vecchione A; Croce CM; Mori M; Huebner K
Cancer Res; 2006 Dec; 66(23):11287-92. PubMed ID: 17145874
[TBL] [Abstract][Full Text] [Related]
38. Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.
Zuo H; Chan GP; Zhu J; Yeung WW; Chan AS; Ammer H; Wong YH
Cell Commun Signal; 2013 Aug; 11():59. PubMed ID: 23947369
[TBL] [Abstract][Full Text] [Related]
39. Stereochemical retention of the configuration in the action of Fhit on phosphorus-chiral substrates.
Abend A; Garrison PN; Barnes LD; Frey PA
Biochemistry; 1999 Mar; 38(12):3668-76. PubMed ID: 10090754
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue.
Lilge L; Portnoy M; Wilson BC
Br J Cancer; 2000 Oct; 83(8):1110-7. PubMed ID: 10993661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
